(80 days)
Not Found
Not Found
I am sorry, but the provided text is a letter from the FDA to a medical device manufacturer, indicating that a device (an electrocardiograph electrode) has been found substantially equivalent to a legally marketed predicate device.
This document does not contain information about:
- Acceptance criteria and reported device performance: It doesn't detail any specific performance metrics or thresholds for the electrode.
- Sample size, data provenance, number of experts, adjudication method, or ground truth for a study: The letter refers to a "510(k) premarket notification," which typically includes performance data, but the data itself and supporting study details are not present in this FDA letter.
- MRMC comparative effectiveness study or standalone algorithm performance: The device is an electrode, not an AI algorithm, so these types of studies would not be relevant.
- Training set sample size or how ground truth was established for a training set: Again, these details are related to algorithm development, which is not applicable here.
Therefore, I cannot fulfill your request for this specific information based on the provided text. The letter is an FDA clearance document, not a study report.
§ 870.2360 Electrocardiograph electrode.
(a)
Identification. An electrocardiograph electrode is the electrical conductor which is applied to the surface of the body to transmit the electrical signal at the body surface to a processor that produces an electrocardiogram or vectorcardiogram.(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9. The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Electrocardiograph Electrodes.” See § 870.1(e) for availability information of guidance documents.